Kallikrein 15 Antikörper (AA 75-87)
Kurzübersicht für Kallikrein 15 Antikörper (AA 75-87) (ABIN636239)
Target
Alle Kallikrein 15 (KLK15) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 75-87
-
Kreuzreaktivität (Details)
- This antibodys immunogens shares 92 % sequence identity with its Mouse, and rat homologs.
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- KLK15 antibody was raised in rabbit using AA 75-87 [HNLRKRDGPEQLR] of the 28 kDa human KLK15 protein as the immunogen.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- Kallikrein 15 (KLK15) (Kallikrein-Related Peptidase 15 (KLK15))
-
Andere Bezeichnung
- KLK15
-
Hintergrund
- This is a novel human kallikrein gene. Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. KLK15 is up-regulated in more aggressive forms of prostate cancer, which indicates its potential use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and is alternatively spliced. Four splice variants, each encoding a distinct isoform, have been described.
-
Pathways
- Komplementsystem
Target
-